Caldwell Trust’s DexCom DXCM Stock Holding History

Caldwell Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$909K	Buy	13,491 +9,164	+212%	+$611K	0.07%	176
2026 Q1	$272K	Buy	+4,327	New	+$301K	0.02%	292

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Caldwell Trust's DXCM Position: Q2 2026 in Review

Caldwell Trust increased its DexCom (DXCM) stake by 212% in Q2 2026, buying an estimated $611K and bringing the position to 13,491 shares worth $909K. The position accounts for 0.07% of the portfolio, ranked #176.

Caldwell Trust first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Caldwell Trust held 13,491 shares of DexCom worth $909K as of Q2 2026.
Caldwell Trust bought 9,164 DexCom shares in Q2 2026, an estimated $611K.
DexCom made up 0.07% of Caldwell Trust's portfolio in Q2 2026, its #176 holding.
Caldwell Trust first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.